China Biologic Announces Completion of Going Private Transaction
News provided by
Share this article
Share this article
BEIJING, April 20, 2021 /PRNewswire/ China Biologic Products Holdings, Inc. (NASDAQ: CBPO, China Biologic or the Company ), a leading fully integrated plasma-based biopharmaceutical company in China, today announced the completion of its merger (the Merger ) with CBPO Group Limited ( Merger Sub ), a wholly owned subsidiary of CBPO Holdings Limited ( Parent ), pursuant to the previously announced agreement and plan of merger, dated as of November 19, 2020 (the Merger Agreement ) among the Company, Parent and Merger Sub. As a result of the Merger, the Company became a wholly owned subsidiary of Parent and will cease to be a publicly traded company.
Logitech Combo Touch Available for New iPad Pro 12 9 (5th generation) and iPad Pro 11 (3rd generation) digitalmedianet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from digitalmedianet.com Daily Mail and Mail on Sunday newspapers.
Get full access to all content,
just $1 for 30 days
A Message From The Editor
just-food gives you the widest food market coverage.
But only paid just-food members have full, unlimited access to all our exclusive content - including 21 years of archives.
Try just-food for 30 days and get the research report; âIs sugar the next tobaccoâ for free!
Dean Best, editor of just-food
Ruhnn Announces Completion of Going Private Transaction prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Iridium Announces First-Quarter 2021 Results prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.